Drugmakers, hospitals at odds over 340B discounts

02/12/2013 | New York Times (tiered subscription model), The

The pharmaceutical industry and hospitals are fighting over the federally mandated 340B drug discount program. Some hospitals use the program as a revenue source instead of helping poor patients, BIO and other industry groups say in a report. Hospitals argue that 340B was designed to stretch resources and support hospitals that serve the poor. Congressional Republicans and looking into the program.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY